12:56 PM EDT, 06/27/2024 (MT Newswires) -- Denali Capital Acquisition ( DECA ) said Thursday that it and Longevity Biomedical have mutually agreed to terminate their proposed business combination deal.
Denali said it will seek "alternative ways to consummate an initial business combination."
Shares of the blank-check company surged more than 46% in recent trading.
Price: 11.35, Change: +3.58, Percent Change: +46.04